Preventive effect of statins for hepatocellular carcinoma / 肿瘤研究与临床
Cancer Research and Clinic
;
(6): 501-504, 2016.
Artículo
en Chino
| WPRIM
| ID: wpr-495468
ABSTRACT
Statins, hydroxymethylglutaryl coenzyme A (HMG-CoA) reductase inhibitors , are widely used as a class of lipid-lowering drugs in clinic. Recent studies have shown that the use of statins can be anti-inflammatory, anti-fibrosis and reduce the incidence of hepatocellular carcinoma (HCC), which may provide a new method for the preventive treatment of HCC. This article will review the current research progress of statins, including the clinical evidence, the molecular mechanisms of anti-inflammatory, anti-fibrosis and anti-tumor in liver.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Idioma:
Chino
Revista:
Cancer Research and Clinic
Año:
2016
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS